SCHEMBL7650879

SCHEMBL7650879

CC(C)=CCC(C)(C=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
TSHR P16473 4/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
ADRB2 P07550 1/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
CYP3A4 P08684 1/20 0.37
ABCB11 O95342 1/20 0.35
LMNA P02545 1/20 0.35
PTGS1 P23219 1/20 0.35
TAAR1 Q96RJ0 1/20 0.34
ALOX15 P16050 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10824507 0.86 MMP1 (0.42) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL30118205 0.83 ALDH1A1 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL28792070 0.83 ALDH1A1 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL4699693 0.78 ALDH1A1 (0.44) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL4710826 0.78 ALDH1A1 (0.50) ALDH1A1TSHRKMT2AMEN1CYP2C19
SCHEMBL16213089 0.77 ALDH1A1 (0.46) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL341054 0.77 CYP2C19 (0.44) ALDH1A1TSHRKMT2AMEN1CYP2C19
SCHEMBL10959995 0.76 CYP2C19 (0.36) ALDH1A1TSHRKMT2ACYP2C19HIF1A
SCHEMBL31312685 0.76 CYP2C19 (0.44) ALDH1A1TSHRKMT2AMEN1CYP2C19
SCHEMBL10959990 0.76 CYP2C19 (0.36) ALDH1A1TSHRKMT2ACYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-61001634-A None JP disclosed
US-6476054-B1 Cyclic amine modulators of chemokine receptor activity MERCK & CO., INC. 2002-11-05 US disclosed
EP-1052992-A1 CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2000-11-22 EP disclosed
US-6140349-A FOR PROPHYLAXIS AND THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS(HIV) INFECTIONS AND ACQUIRED IMMUNODEDICIENCY SYNDROME MERCK & CO., INC. (US) 2000-10-31 US disclosed
US-6136827-A PIPERIDINE COMPOUNDS AS DRUGS MERCK & CO., INC. (US) 2000-10-24 US disclosed
EP-1003514-A1 CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2000-05-31 EP disclosed
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
WO-1999038514-A1 CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1999-08-05 WO disclosed
WO-1999004794-A1 CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1999-02-04 WO disclosed
WO-1998025605-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
JP-S611634-A PREPARATION OF ALPHA-PHENYL-GAMMA, DELTA-UNSATURATED ALDEHYDE KURARAY CO LTD 1986-01-07 JP disclosed